Get started
Author

Hitoshi Kusaba

Observed names: H Kusaba, H. Kusaba, HITOSHI KUSABA
Observed institutions: University of Miyazaki, National Institutes of Health, Kyushu University, University of Occupational and Environmental Health Japan, National Kyushu Medical Center, Fukuoka University, Nagoya City University, Shizuoka Cancer Center, Kyushu University Hospital, Hamanomachi Hospital, Miyazaki Prefectural Hospital, Ono Pharmaceutical (Japan), Chiba Cancer Center, University of Miyazaki Hospital, National Institute on Aging, National Hospital Organization, Shikoku Cancer Center, National Cancer Center Hospital East, Kyushu University Beppu Hospital, Fukuoka Wajiro Hospital, Tokyo Cooperative Oncology Group, National Cancer Center Hospital, Aichi Cancer Center Hospital, National Cancer Center Research Institute
ORCID: 0000-0002-2949-5970
Observed ORCID: 0000-0002-2949-5970
OpenAlex ID: A5070901487
Hypomethylation Status of CpG Sites at the Promoter Region and Overexpression of the Human MDR1 Gene in Acute Myeloid Leukemias
1998 · Masaharu Nakayama, Morimasa Wada, et al. · Blood · 174
Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer
2018 · Michitaka Nakano, Yoshikane Kikushige, et al. · Oncogene · 122
Effect of Promoter Methylation on the Regulation of IFN- γ Gene During In Vitro Differentiation of Human Peripheral Blood T Cells into a Th2 Population
2003 · Shingo Yano, Paritosh Ghosh, et al. · The Journal of Immunology · 112
PDF
RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells
2020 · Nobuhiro Tsuruta, Kenji Tsuchihashi, et al. · Biochemical and Biophysical Research Communications · 97
OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody
2020 · Hirofumi Ohmura, Kyoko Yamaguchi, et al. · British Journal of Cancer · 80
PDF
Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer
2020 · Kyoko Yamaguchi, Mamoru Ito, et al. · OncoImmunology · 75
PDF
Phase I/ II trial of 2‐weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer ( JCOG 0807)
2014 · Shuichi Hironaka, Yasuhiro Tsubosa, et al. · Cancer Science · 72
PDF
Association of 5′ CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells
1999 · Hitoshi Kusaba, Masaharu Nakayama, et al. · European Journal of Biochemistry · 67
Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer
2017 · Akitaka Makiyama, Kohei Arimizu, et al. · Gastric Cancer · 63
PDF
B cell activation regulates exosomal HLA production
2008 · Shuji Arita, Eishi Baba, et al. · European Journal of Immunology · 59
Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer
2024 · Kenro Tanoue, Hirofumi Ohmura, et al. · Nature Communications · 56
PDF
Interleukin-12-induced Interferon-γ Production by Human Peripheral Blood T Cells Is Regulated by Mammalian Target of Rapamycin (mTOR)
2004 · Hitoshi Kusaba, Paritosh Ghosh, et al. · Journal of Biological Chemistry · 56
PDF
Enhanced Expression of PCAF Endows Apoptosis Resistance in Cisplatin-Resistant Cells
2010 · Gen Hirano, Hiroto Izumi, et al. · Molecular Cancer Research · 49
Activation of central/effector memory T cells and T‐helper 1 polarization in malignant melanoma patients treated with anti‐ programmed death ‐1 antibody
2018 · Kyoko Yamaguchi, Koji Mishima, et al. · Cancer Science · 47
PDF
Immune-checkpoint profiles for T cells in bronchoalveolar lavage fluid of patients with immune-checkpoint inhibitor-related interstitial lung disease
2020 · Kunihiro Suzuki, Toyoshi Yanagihara, et al. · International Immunology · 46
Human STEAP3 maintains tumor growth under hypoferric condition
2011 · Taichi Isobe, Eishi Baba, et al. · Experimental Cell Research · 46
PD ‐1+ TIM ‐3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer
2018 · Michitaka Nakano, Mamoru Ito, et al. · Cancer Science · 45
PDF
Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells
2006 · Baoli Qin, Hiroshi Ariyama, et al. · Cancer Chemotherapy and Pharmacology · 41
Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus
2016 · Kyoko Inadomi, Hozumi Kumagai, et al. · Medicine · 38
Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan
2009 · Yoshihiro Shibata, Hiroshi Ariyama, et al. · International Journal of Clinical Oncology · 35
E‑cadherin regulates proliferation of colorectal cancer stem cells through NANOG
2018 · Shingo Tamura, Taichi Isobe, et al. · Oncology Reports · 32
PDF
Human Nanog pseudogene8 promotes the proliferation of gastrointestinal cancer cells
2012 · Keita Uchino, Gen Hirano, et al. · Experimental Cell Research · 31
Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer
2017 · Kotoe Takayoshi, Hitoshi Kusaba, et al. · Cancer Chemotherapy and Pharmacology · 30
PDF
Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumab
2021 · Kenro Tanoue, Shingo Tamura, et al. · Scientific Reports · 29
PDF
Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients
2019 · Kotoe Takayoshi, Hitoshi Kusaba, et al. · Gastric Cancer · 28
PDF
Works count: 169
Citation count: 2,324
H-index: 26
I10-index: 56
Year
Topic
Type